We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PIR
2351
DELISTED
Pier 1 Imports, Inc.
PIR
$16K ﹤0.01%
+97
New +$11.2K
MRT
2352
DELISTED
MedEquities Realty Trust, Inc.
MRT
$16K ﹤0.01%
+1,449
New +$16.2K
ARII
2353
DELISTED
American Railcar Industries, Inc.
ARII
$16K ﹤0.01%
+340
New +$14.4K
PF
2354
DELISTED
Pinnacle Foods, Inc.
PF
$16K ﹤0.01%
300
-1,420
-83% -$72K
QCP
2355
DELISTED
Quality Care Properties, Inc.
QCP
$16K ﹤0.01%
+1,059
New +$15.9K
CLMS
2356
DELISTED
Calamos Asset Management, Inc.
CLMS
$16K ﹤0.01%
1,864
+1,182
+173% +$8.2K
PGEM
2357
DELISTED
Ply Gem Holdings, Inc.
PGEM
$16K ﹤0.01%
+985
New +$14.7K
OREX
2358
DELISTED
Orexigen Therapeutics, Inc.
OREX
$16K ﹤0.01%
9,173
+3,707
+68% +$8.71K
MNR
2359
DELISTED
Monmouth Real Estate Investment Corp
MNR
$16K ﹤0.01%
+1,054
New +$14.6K
AGYS icon
2360
Agilysys
AGYS
$3.06B
$15K ﹤0.01%
1,447
+368
+34% +$3.8K
ANGO icon
2361
AngioDynamics
ANGO
$649M
$15K ﹤0.01%
+915
New +$15.3K
ATNI icon
2362
ATN International
ATNI
$492M
$15K ﹤0.01%
+185
New +$13.2K
BHV icon
2363
BlackRock Virginia Muni Bond Trust
BHV
$20.3M
$15K ﹤0.01%
1,000
+115
+13% +$1.99K
BLKB icon
2364
Blackbaud
BLKB
$2.08B
$15K ﹤0.01%
+232
New +$14.8K
BUSE icon
2365
First Busey Corp
BUSE
$2.56B
$15K ﹤0.01%
481
+81
+20% +$2.11K
BW icon
2366
Babcock & Wilcox
BW
$1.39B
$15K ﹤0.01%
93
+83
+830% +$13.2K
CAC icon
2367
Camden National
CAC
$976M
$15K ﹤0.01%
+340
New +$12.5K
CIA icon
2368
Citizens
CIA
$192M
$15K ﹤0.01%
1,501
-116
-7% -$1.07K
CX icon
2369
Cemex
CX
$16.3B
$15K ﹤0.01%
1,976
-30,576
-94% -$243K
EMTL
2370
DELISTED
State Street DoubleLine Emerging Markets Fixed Income ETF
EMTL
$15K ﹤0.01%
+300
New +$15.6K
FBK icon
2371
FB Financial Corp
FBK
$3.04B
$15K ﹤0.01%
596
+496
+496% +$11.3K
HBM icon
2372
Hudbay
HBM
$12.3B
$15K ﹤0.01%
2,577
-32,393
-93% -$173K
HONE
2373
DELISTED
HarborOne Bancorp
HONE
$15K ﹤0.01%
1,397
-8,029
-85% -$80K
IFN
2374
Aberdeen India Fund
IFN
$504M
$15K ﹤0.01%
+690
New +$16.1K
JBLU icon
2375
JetBlue
JBLU
$2.29B
$15K ﹤0.01%
665
-20,413
-97% -$403K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.